JeanGilles explains that modest changes in hunger or appetite are expected early on, and side effects like mild fatigue or stomach upset tend to lessen as treatment continues
When used under medical supervision, semaglutide GLP-1 can help reduce hunger, increase feelings of fullness, and support significant weight loss by decreasing calorie intake
First, it reduced the frequency and severity of gastrointestinal events such as nausea, vomiting, and diarrhoea, which are common with incretin-based therapies
This additional glucagon receptor activity is thought to further increase energy expenditure and promote hepatic fat reduction, though its precise contribution in humans is still under investigation
I was taking Zepbound for over six months and increased my dose to 10 mg
Forum on Neuroscience and Nervous System Disorders